Lisa Malburg

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral MAPK/ERK Kinase Inhibitor PD-0325901 in Patients with Advanced Cancers

Patricia LoRusso, Smitha Krishnamurthi, John J. Rinehart et al. · Clinical Cancer Research · 2010 · 250 citations

Pharmacy, Pharmacokinetics, Pharmacotherapy +17

Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors

Edward A. Sausville, Patricia LoRusso, Michael A. Carducci et al. · Cancer Chemotherapy and Pharmacology · 2014 · 197 citations · Full text

Medicine, Oncology, Pharmacology +15

Phase 1 First-in-Human Trial of the Vascular Disrupting Agent Plinabulin(NPI-2358) in Patients with Solid Tumors or Lymphomas

Monica Mita, Matthew A. Spear, Lorrin Yee et al. · Clinical Cancer Research · 2010 · 107 citations

Medicine, Oncology, Pharmacology +16

A Phase I Study of the Pharmacokinetic and Safety Profiles of Oral Pazopanib With a High-Fat or Low-Fat Meal in Patients With Advanced Solid Tumors

Elisabeth I. Heath, E. Gabriela Chiorean, Christopher J. Sweeney et al. · Clinical Pharmacology & Therapeutics · 2010 · 100 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Phase I Study of Folate Conjugate EC145 (Vintafolide) in Patients With Refractory Solid Tumors

Patricia LoRusso, Martin J. Edelman, S. Bever et al. · Journal of Clinical Oncology · 2012 · 94 citations · Full text

Medicine, Oncology, Pharmacology +14